Summary

The global opioids market remains a vital segment within the broader pharmaceutical industry, driven by the continued need for effective pain management therapies. Opioids are widely used in treating moderate to severe pain, especially in cases related to cancer, post-surgical recovery, and chronic illnesses. While concerns regarding misuse and dependency persist, ongoing advancements in drug development and stricter regulatory frameworks are helping shape a more controlled and responsible market landscape. The industry is increasingly focused on balancing patient access with safety, which continues to influence growth patterns worldwide.

Market Insights

The opioids market is expected to reach USD 45.2 billion in 2026 and expand to USD 64 billion by 2033, registering a CAGR of 5.10% during the forecast period. This steady growth reflects the ongoing demand for opioid medications in clinical settings, particularly in pain management therapies. Improvements in healthcare infrastructure, especially in developing regions, and increased awareness about effective pain treatment are contributing to market expansion. Additionally, innovation in extended-release and abuse-deterrent formulations is enhancing patient safety and supporting sustained market demand.

Market Drivers

The increasing incidence of chronic diseases such as cancer, musculoskeletal disorders, and neuropathic conditions is a major factor driving the opioids market. These conditions often require long-term pain management, leading to consistent demand for opioid-based medications. The growing elderly population globally is another significant driver, as aging individuals are more prone to chronic pain and related health conditions.

Furthermore, the rising number of surgical procedures worldwide is increasing the demand for opioids for post-operative pain relief. Pharmaceutical companies are investing heavily in research and development to create safer formulations, including abuse-deterrent opioids, which help reduce the risk of misuse. Government initiatives aimed at improving pain management practices and raising awareness among healthcare professionals also contribute to market growth.

Business Opportunity

The opioids market offers considerable opportunities for innovation and expansion. Pharmaceutical companies are focusing on developing next-generation opioid drugs with improved safety profiles and reduced side effects. Combination therapies that integrate opioids with non-opioid analgesics are gaining traction as they provide effective pain relief with lower dependency risks.

Emerging markets, particularly in Asia Pacific and Latin America, present strong growth potential due to increasing healthcare access and rising patient awareness. Additionally, the integration of digital health tools, such as prescription monitoring systems, is enabling better regulation and responsible usage of opioids. Strategic collaborations between pharmaceutical firms and healthcare providers are further enhancing treatment efficiency and expanding market presence.

Region Analysis

North America continues to lead the opioids market, supported by advanced healthcare systems and a high prevalence of chronic pain conditions. However, strict regulatory measures and growing awareness about opioid misuse have led to more controlled prescribing practices in the region.

Europe represents a stable market with moderate growth, driven by well-established healthcare infrastructure and increasing focus on safe pain management practices. Regulatory authorities in Europe emphasize controlled distribution, which supports sustainable market development.

Asia Pacific is projected to experience the fastest growth, fueled by rapid healthcare development, increasing patient awareness, and a large population base. Countries such as China and India are witnessing rising demand for pain management solutions, supported by expanding pharmaceutical industries.

Latin America and the Middle East and Africa are gradually emerging as promising markets. Improvements in healthcare infrastructure and increased investments in medical services are expected to boost demand for opioid medications in these regions over the forecast period.

Key Players

• Johnson & Johnson

• Pfizer Inc.

• Teva Pharmaceutical Industries Ltd.

• Mallinckrodt Pharmaceuticals

• Endo International plc

• Purdue Pharma L.P.

• Sanofi

• Sun Pharmaceutical Industries Ltd.

• Hikma Pharmaceuticals PLC

• Mylan N.V.

• Viatris Inc.

• Novartis AG

• Bausch Health Companies Inc.

• Dr. Reddy's Laboratories Ltd.

• Aurobindo Pharma Ltd.

Segmentation

By Product Type

• Morphine

• Codeine

• Fentanyl

• Methadone

• Others

By Application

• Pain Management

• Cough Treatment

• Diarrhea Treatment

• Opioid De-Addiction

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Opioids Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Opioids Market Outlook, 2020 - 2033
3.1. Global Opioids Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
3.1.1. Morphine
3.1.2. Codeine
3.1.3. Fentanyl
3.1.4. Methadone
3.1.5. Others
3.2. Global Opioids Market Outlook, by Application, Value (US$ Bn), 2020-2033
3.2.1. Pain Management
3.2.2. Cough Treatment
3.2.3. Diarrhea Treatment
3.2.4. Opioid De-Addiction
3.3. Global Opioids Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
3.3.1. Hospital Pharmacies
3.3.2. Retail Pharmacies
3.3.3. Online Pharmacies
3.4. Global Opioids Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Opioids Market Outlook, 2020 - 2033
4.1. North America Opioids Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
4.1.1. Morphine
4.1.2. Codeine
4.1.3. Fentanyl
4.1.4. Methadone
4.1.5. Others
4.2. North America Opioids Market Outlook, by Application, Value (US$ Bn), 2020-2033
4.2.1. Pain Management
4.2.2. Cough Treatment
4.2.3. Diarrhea Treatment
4.2.4. Opioid De-Addiction
4.3. North America Opioids Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
4.3.1. Hospital Pharmacies
4.3.2. Retail Pharmacies
4.3.3. Online Pharmacies
4.4. North America Opioids Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Opioids Market Outlook, by Product Type, 2020-2033
4.4.2. U.S. Opioids Market Outlook, by Application, 2020-2033
4.4.3. U.S. Opioids Market Outlook, by Distribution Channel, 2020-2033
4.4.4. Canada Opioids Market Outlook, by Product Type, 2020-2033
4.4.5. Canada Opioids Market Outlook, by Application, 2020-2033
4.4.6. Canada Opioids Market Outlook, by Distribution Channel, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Opioids Market Outlook, 2020 - 2033
5.1. Europe Opioids Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
5.1.1. Morphine
5.1.2. Codeine
5.1.3. Fentanyl
5.1.4. Methadone
5.1.5. Others
5.2. Europe Opioids Market Outlook, by Application, Value (US$ Bn), 2020-2033
5.2.1. Pain Management
5.2.2. Cough Treatment
5.2.3. Diarrhea Treatment
5.2.4. Opioid De-Addiction
5.3. Europe Opioids Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
5.3.1. Hospital Pharmacies
5.3.2. Retail Pharmacies
5.3.3. Online Pharmacies
5.4. Europe Opioids Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Opioids Market Outlook, by Product Type, 2020-2033
5.4.2. Germany Opioids Market Outlook, by Application, 2020-2033
5.4.3. Germany Opioids Market Outlook, by Distribution Channel, 2020-2033
5.4.4. Italy Opioids Market Outlook, by Product Type, 2020-2033
5.4.5. Italy Opioids Market Outlook, by Application, 2020-2033
5.4.6. Italy Opioids Market Outlook, by Distribution Channel, 2020-2033
5.4.7. France Opioids Market Outlook, by Product Type, 2020-2033
5.4.8. France Opioids Market Outlook, by Application, 2020-2033
5.4.9. France Opioids Market Outlook, by Distribution Channel, 2020-2033
5.4.10. U.K. Opioids Market Outlook, by Product Type, 2020-2033
5.4.11. U.K. Opioids Market Outlook, by Application, 2020-2033
5.4.12. U.K. Opioids Market Outlook, by Distribution Channel, 2020-2033
5.4.13. Spain Opioids Market Outlook, by Product Type, 2020-2033
5.4.14. Spain Opioids Market Outlook, by Application, 2020-2033
5.4.15. Spain Opioids Market Outlook, by Distribution Channel, 2020-2033
5.4.16. Russia Opioids Market Outlook, by Product Type, 2020-2033
5.4.17. Russia Opioids Market Outlook, by Application, 2020-2033
5.4.18. Russia Opioids Market Outlook, by Distribution Channel, 2020-2033
5.4.19. Rest of Europe Opioids Market Outlook, by Product Type, 2020-2033
5.4.20. Rest of Europe Opioids Market Outlook, by Application, 2020-2033
5.4.21. Rest of Europe Opioids Market Outlook, by Distribution Channel, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Opioids Market Outlook, 2020 - 2033
6.1. Asia Pacific Opioids Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
6.1.1. Morphine
6.1.2. Codeine
6.1.3. Fentanyl
6.1.4. Methadone
6.1.5. Others
6.2. Asia Pacific Opioids Market Outlook, by Application, Value (US$ Bn), 2020-2033
6.2.1. Pain Management
6.2.2. Cough Treatment
6.2.3. Diarrhea Treatment
6.2.4. Opioid De-Addiction
6.3. Asia Pacific Opioids Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.4. Asia Pacific Opioids Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Opioids Market Outlook, by Product Type, 2020-2033
6.4.2. China Opioids Market Outlook, by Application, 2020-2033
6.4.3. China Opioids Market Outlook, by Distribution Channel, 2020-2033
6.4.4. Japan Opioids Market Outlook, by Product Type, 2020-2033
6.4.5. Japan Opioids Market Outlook, by Application, 2020-2033
6.4.6. Japan Opioids Market Outlook, by Distribution Channel, 2020-2033
6.4.7. South Korea Opioids Market Outlook, by Product Type, 2020-2033
6.4.8. South Korea Opioids Market Outlook, by Application, 2020-2033
6.4.9. South Korea Opioids Market Outlook, by Distribution Channel, 2020-2033
6.4.10. India Opioids Market Outlook, by Product Type, 2020-2033
6.4.11. India Opioids Market Outlook, by Application, 2020-2033
6.4.12. India Opioids Market Outlook, by Distribution Channel, 2020-2033
6.4.13. Southeast Asia Opioids Market Outlook, by Product Type, 2020-2033
6.4.14. Southeast Asia Opioids Market Outlook, by Application, 2020-2033
6.4.15. Southeast Asia Opioids Market Outlook, by Distribution Channel, 2020-2033
6.4.16. Rest of SAO Opioids Market Outlook, by Product Type, 2020-2033
6.4.17. Rest of SAO Opioids Market Outlook, by Application, 2020-2033
6.4.18. Rest of SAO Opioids Market Outlook, by Distribution Channel, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Opioids Market Outlook, 2020 - 2033
7.1. Latin America Opioids Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
7.1.1. Morphine
7.1.2. Codeine
7.1.3. Fentanyl
7.1.4. Methadone
7.1.5. Others
7.2. Latin America Opioids Market Outlook, by Application, Value (US$ Bn), 2020-2033
7.2.1. Pain Management
7.2.2. Cough Treatment
7.2.3. Diarrhea Treatment
7.2.4. Opioid De-Addiction
7.3. Latin America Opioids Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Latin America Opioids Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Opioids Market Outlook, by Product Type, 2020-2033
7.4.2. Brazil Opioids Market Outlook, by Application, 2020-2033
7.4.3. Brazil Opioids Market Outlook, by Distribution Channel, 2020-2033
7.4.4. Mexico Opioids Market Outlook, by Product Type, 2020-2033
7.4.5. Mexico Opioids Market Outlook, by Application, 2020-2033
7.4.6. Mexico Opioids Market Outlook, by Distribution Channel, 2020-2033
7.4.7. Argentina Opioids Market Outlook, by Product Type, 2020-2033
7.4.8. Argentina Opioids Market Outlook, by Application, 2020-2033
7.4.9. Argentina Opioids Market Outlook, by Distribution Channel, 2020-2033
7.4.10. Rest of LATAM Opioids Market Outlook, by Product Type, 2020-2033
7.4.11. Rest of LATAM Opioids Market Outlook, by Application, 2020-2033
7.4.12. Rest of LATAM Opioids Market Outlook, by Distribution Channel, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Opioids Market Outlook, 2020 - 2033
8.1. Middle East & Africa Opioids Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
8.1.1. Morphine
8.1.2. Codeine
8.1.3. Fentanyl
8.1.4. Methadone
8.1.5. Others
8.2. Middle East & Africa Opioids Market Outlook, by Application, Value (US$ Bn), 2020-2033
8.2.1. Pain Management
8.2.2. Cough Treatment
8.2.3. Diarrhea Treatment
8.2.4. Opioid De-Addiction
8.3. Middle East & Africa Opioids Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Middle East & Africa Opioids Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Opioids Market Outlook, by Product Type, 2020-2033
8.4.2. GCC Opioids Market Outlook, by Application, 2020-2033
8.4.3. GCC Opioids Market Outlook, by Distribution Channel, 2020-2033
8.4.4. South Africa Opioids Market Outlook, by Product Type, 2020-2033
8.4.5. South Africa Opioids Market Outlook, by Application, 2020-2033
8.4.6. South Africa Opioids Market Outlook, by Distribution Channel, 2020-2033
8.4.7. Egypt Opioids Market Outlook, by Product Type, 2020-2033
8.4.8. Egypt Opioids Market Outlook, by Application, 2020-2033
8.4.9. Egypt Opioids Market Outlook, by Distribution Channel, 2020-2033
8.4.10. Nigeria Opioids Market Outlook, by Product Type, 2020-2033
8.4.11. Nigeria Opioids Market Outlook, by Application, 2020-2033
8.4.12. Nigeria Opioids Market Outlook, by Distribution Channel, 2020-2033
8.4.13. Rest of Middle East Opioids Market Outlook, by Product Type, 2020-2033
8.4.14. Rest of Middle East Opioids Market Outlook, by Application, 2020-2033
8.4.15. Rest of Middle East Opioids Market Outlook, by Distribution Channel, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Johnson & Johnson
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Pfizer Inc.
9.4.3. Teva Pharmaceutical Industries Ltd.
9.4.4. Mallinckrodt Pharmaceuticals
9.4.5. Endo International plc
9.4.6. Purdue Pharma L.P.
9.4.7. Sanofi
9.4.8. Sun Pharmaceutical Industries Ltd.
9.4.9. Hikma Pharmaceuticals PLC
9.4.10. Mylan N.V.
9.4.11. Viatris Inc.
9.4.12. Novartis AG
9.4.13. Bausch Health Companies Inc.
9.4.14. Dr. Reddy's Laboratories Ltd.
9.4.15. Aurobindo Pharma Ltd.
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations